KOSDAQMachinery079810

APS Innovation

₩3,025▲ 0.67%2026-11-18 close
Market Cap
₩65.1B
Turnover
₩100M
Volume
40K
Shares out.
21.5M
PER
12.0×
PBR
0.4×
EPS
₩271
Dividend Yield
0.00%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩0 per share · Prices as of the 2026-11-18 close

01

Report overview

Operating profit recovers, Q3 net loss emerges

APS Innovation lifted Q3 2026 operating profit to KRW 4.68 billion but swung to a KRW 3.41 billion net loss attributable to controlling shareholders, as its battery-equipment cycle and newly added cosmetics-equipment business both shape the picture.

  1. 1

    Annual revenue peaked at KRW 146.4 billion in 2024 and fell 49.5% to KRW 74 billion in 2025.

  2. 2

    Q3 2026 operating profit of KRW 4.68 billion rose 828.1% year on year, while the controlling-shareholder result turned into a KRW 3.41 billion net loss.

  3. 3

    In August 2026 the company agreed to acquire ERAE, a cosmetics filling and packaging automation equipment maker, as part of a KRW 24.5 billion package, to diversify its business.

  4. 4

    A KRW 13.6 billion new plant in Cheonan, decided in June 2026, is scheduled for completion in late January 2027.

  5. 5

    With total equity of KRW 166.3 billion at end-2025 and a debt ratio of 32.6%, the company carries a comparatively light debt burden.

02

Business structure

APS Innovation is an equipment maker headquartered in Osan, Gyeonggi, whose core product is laser notching equipment for battery production lines. The company manufactures equipment used in secondary battery and display production processes and treats precision machinery and control technology as its core edge.

A company commentary summarized by a financial information site says that in Q1 2026 its secondary battery unit saw revenue rise sharply on growing battery demand from the electric vehicle market and wider supply of laser notching equipment to major customers in Korea and abroad.

At its March 27, 2026 annual general meeting the company changed its name and listed beauty, hydrogen fuel cells, aircraft parts, CFRP drones and AI data center cooling as areas under review.

In August 2026 it agreed to acquire 100% of the shares of ERAE, a maker of cosmetics filling and packaging automation equipment and OEM services, for KRW 23.5 billion, and the package including an engineering business totaled KRW 24.5 billion.

Media reports cited ERAE's 2025 revenue at KRW 10.8 billion and net income at KRW 1.03 billion. The company has said the cosmetics equipment serves a customer base different from its battery customers, which it expects to lessen dependence on a single downstream industry.

In October 2026 it invested KRW 3.3 billion for a 7.2% stake in a microneedle beauty platform company, becoming a top-four shareholder. The largest shareholder side, APS group entities, holds a significant stake, and a September 2026 disclosure showed an APS group entity's holding rising to 13.49%.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩9.2B₩500M5.5%
2025Q4₩24.9B₩300M1.1%
2026Q1₩19.6B₩3B15.3%
2026Q2₩15.8B₩500M3.4%
2026Q3₩24.7B₩4.7B19.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩50.2B-₩4.5B-₩5.6B−9.0%−23.8%279.7%
2023₩127.4B₩1.7B₩1B1.4%0.7%61.4%
2024₩146.4B₩5.4B₩18.2B3.7%11.0%44.0%
2025₩74B₩2.5B₩89,562,9853.4%0.1%32.6%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-13

04

Earnings analysis

Annual revenue rose from KRW 50.2 billion in 2022 to KRW 127.4 billion in 2023, a 153.9% increase, and reached KRW 146.4 billion in 2024, a 14.9% increase and the largest year of 2022 to 2025. Revenue fell 49.5% to KRW 74 billion in 2025, which is still larger than the 2022 level of KRW 50.2 billion.

Operating results moved from an operating loss of KRW 4.54 billion in 2022 to operating profit of KRW 1.75 billion in 2023, which marked a turn to profit, then to KRW 5.36 billion in 2024, a 206.5% increase, and KRW 2.55 billion in 2025, a 52.4% decline.

The operating margin was -9.0% in 2022, 1.4% in 2023, 3.7% in 2024 and 3.4% in 2025, so margins stayed in the 3% range even as revenue fell sharply in 2025. In its first-half 2026 results announcement, the company attributed the improved profitability to manufacturing cost reductions and productivity gains.

Net income attributable to controlling shareholders moved from KRW 1.02 billion in 2023, a turn to profit, to KRW 18.2 billion in 2024, a 1,693.0% increase. That figure far exceeded 2024 operating profit of KRW 5.36 billion, which suggests non-operating items contributed substantially that year.

Controlling-shareholder net income then fell 99.5% to KRW 89.56 million in 2025. Operating cash flow went from KRW -48.7 billion in 2023 to KRW 8.62 billion in 2024 and KRW 27.9 billion in 2025.

Quarterly revenue rose from KRW 9.21 billion in Q3 2025 to KRW 24.9 billion in Q4 2025, a 170.6% quarter-on-quarter increase, while operating profit slipped to KRW 267 million, down 47.1% from the prior quarter.

Q1 2026 revenue was KRW 19.6 billion, down 21.2% quarter on quarter, yet operating profit jumped to KRW 3 billion, up 1,025.8%. Q2 2026 revenue fell to KRW 15.8 billion, down 19.3%, and operating profit dropped to KRW 535 million, down 82.2%.

Q3 2026 revenue reached KRW 24.7 billion, up 55.7% quarter on quarter and 167.9% year on year, and operating profit reached KRW 4.68 billion, up 828.1% year on year. Controlling-shareholder net income, however, turned into a KRW 3.41 billion net loss, a swing into deficit from a year earlier.

Over the latest four quarters, from Q4 2025 to Q3 2026, controlling-shareholder net income totaled KRW 5.77 billion.

05

Industry analysis

APS Innovation's results depend heavily on the capital spending cycle of its downstream battery industry. Reports attributed the 2025 revenue decline to a shrinking of electric vehicle battery investment after changes to the U.S. Inflation Reduction Act.

In its first-half 2026 results announcement, the company said that slower global battery-industry investment and reduced capex by its customers drove the revenue decline.

By contrast, Q1 2026 revenue was described as lifted by rising battery demand from the growing electric vehicle market and wider supply of laser notching equipment.

Equipment makers see large swings in results depending on when customers plan investments and place orders, so the lag between a demand recovery and actual orders determines the direction of quarterly results.

In cosmetics, the Ministry of Food and Drug Safety reported that Korean cosmetics exports in 2025 rose 11.8% to USD 11.4 billion, a record high. Growth in K-beauty exports has encouraged domestic cosmetics makers to expand production capacity, which the company cites as the rationale for its new business.

In cosmetics filling and packaging automation equipment, ERAE provides the entry route, given its existing trading relationships with major domestic cosmetics ODM companies.

The company's technical strengths are laser precision control and manufacturing capability, and joint research is underway to apply them to automation and inspection functions in cosmetics production equipment.

06

Outlook

The company decided in June 2026 to invest KRW 13.6 billion in a new production facility on a site in Seongeo Industrial Complex in Cheonan. It bought that land in December 2025 from its largest shareholder APS for KRW 9.275 billion.

The investment period runs through January 2027, and the plant is scheduled for completion in late January 2027. Including land purchase and construction, the core-business investment totals KRW 22.875 billion, and adding the KRW 24.5 billion cosmetics automation package brings the total to KRW 47.375 billion.

Press coverage pointed to the need for the expanded core capacity to translate into a recovery in battery-equipment orders, and for the acquired cosmetics automation business to become a stable earnings source.

Industry experts say the key questions are how much of ERAE's expansion orders from K-beauty ODM customers convert into actual orders, and what product lineup the merged entity builds after taking over the engineering business, which will determine how quickly the acquisition cost is recovered.

Closing of the acquisition requires completion of a merger between ERAE and a related company, and the company said no concrete restructuring plan had been decided as of its filing date. The company says it is expanding its beauty business to reduce order and earnings volatility tied to downstream industry conditions.

In October 2026 it invested KRW 3.3 billion for a 7.2% stake in a microneedle beauty platform company and proposed combining that company's microneedle technology with its cosmetics equipment and OEM capabilities.

A joint R&D plan with ERAE aims to develop automation and inspection equipment specialized for small-batch, multi-product production. The next checkpoint is whether the pace of core-business order recovery and the revenue contribution from the beauty business combine to lift results.

07

Valuation

PER
12.0×
PBR
0.4×
ROE
3.5%
EPS
₩271
BPS
₩8,125
Dividend per share
₩0

On a price-to-book basis the share price sits below 1x, and market capitalization is below total equity at end-2025 of KRW 166.3 billion. Earnings-based multiples are sensitive to quarterly swings, because controlling-shareholder net income totaled only KRW 5.77 billion over the latest four quarters.

Multi-year earnings moved from a turn to profit in 2023 to KRW 18.2 billion in 2024 and KRW 89.56 million in 2025, so comparisons against historical multiple ranges carry wide interpretive uncertainty. Dividend-based yield is low, sitting below the industry average on the dividend yield measure.

As a reference point for the acquisition, the KRW 24.5 billion package price falls within an external valuation range of KRW 23.32 billion to KRW 29.471 billion. That external valuation applied a discounted cash flow method with a weighted average cost of capital of 12.28% to 14.28%.

How the valuation is read will depend on whether the operating margin holds near its third-quarter level next quarter and whether the new plant begins contributing revenue after it starts operating.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-13

08

Bull factors

Quarterly operating profit recovery

Q3 2026 operating profit of KRW 4.68 billion rose 828.1% year on year, and revenue in the same quarter rose 167.9% to KRW 24.7 billion. Q1 2026 operating profit was KRW 3 billion, up 1,025.8% from the prior quarter. The company attributes the improvement to manufacturing cost reductions and productivity gains.

Signs of battery demand recovery

Q1 2026 revenue in the secondary battery unit was described as lifted by rising EV-driven battery demand and wider supply of laser notching equipment to major domestic and overseas customers. This can be read as an early sign of recovery from the investment contraction that cut 2025 revenue by 49.5%. However, Q2 2026 revenue fell 19.3% quarter on quarter, so the trend varied from quarter to quarter.

Financial capacity and diversification

Operating cash flow in 2025 was KRW 27.9 billion, up from KRW 8.62 billion in 2024, and the debt ratio at end-2025 was 32.6%. Standalone cash and cash equivalents reached KRW 86.612 billion at the end of Q1 2026.

The company is pursuing cosmetics automation and a beauty platform stake to lower its dependence on a single downstream industry.

09

Bear factors

Dependence on the downstream investment cycle

Revenue fell 49.5% to KRW 74 billion in 2025, and the company itself cited delayed global battery-industry investment and reduced customer capex as causes. Q2 2026 revenue was KRW 15.8 billion, down 19.3% from the prior quarter. Demand for equipment still depends on when customers place orders.

Swing to a Q3 net loss

Q3 2026 operating profit was KRW 4.68 billion in the black, yet the controlling-shareholder result was a KRW 3.41 billion net loss, a swing into deficit from a year earlier. The divergence between the two measures raises questions about earnings quality. Controlling-shareholder net income over the latest four quarters totaled only KRW 5.77 billion.

Large investment and acquisition burden

Total investment in 2026 comes to KRW 47.375 billion, combining KRW 22.875 billion in core-business facilities with the KRW 24.5 billion cosmetics automation package. The acquisition equals 14.13% of end-2025 equity, and one analysis calculated it at roughly 22.8 times ERAE's 2025 net income.

That price covers a package that includes a stake in a related company and an engineering business, so it is difficult to judge from ERAE's standalone figures alone.

10

Risk factors

Swings in downstream capex

When battery capex slows, equipment orders are delayed, as the 2025 results illustrated. Because the customer base is concentrated in battery equipment, timing differences in orders from a few customers can move quarterly results sharply. Both Q1 and Q2 2026 saw double-digit quarter-on-quarter revenue declines, consistent with this pattern.

Integration and execution of new businesses

Closing of the ERAE acquisition is conditioned on completing a merger between ERAE and a related company, and the merger and payment schedules can be changed by agreement.

Cosmetics equipment serves different customers and sells through different order channels than battery equipment, so existing capabilities may not transfer fully. The company has said no concrete restructuring plan has been set.

Shareholder structure and float

The largest shareholder side, APS group entities, holds a large share, and a September 2026 disclosure showed a group entity's stake rising to 13.49%. A high share held by the controlling side can limit the number of shares trading in the market and widen price swings. Being a small-cap stock also affects trading conditions.

11

What to watch next

  1. Late January 2027

    Scheduled completion of the KRW 13.6 billion Cheonan plant, with the investment period ending in January 2027. Whether operations after completion link to a recovery in battery-equipment orders is the next checkpoint.

  2. Timing undetermined (before deal closing)

    Completion of the merger between ERAE and a related company and the closing date of the package acquisition. The product lineup of the merged entity and the conversion of K-beauty expansion orders into contracts are the points to watch.

  3. End of March 2027

    Deadline for the 2026 annual business report, which will disclose Q4 2026 and full-year revenue, operating profit and controlling-shareholder net income. Whether the full-year operating margin exceeds the 2025 level of 3.4% is the next checkpoint.

  4. Around May 15, 2027

    Filing of the Q1 2027 quarterly report. Whether the Cheonan plant's operating effect and the revenue contribution from cosmetics automation appear in the numbers is the point to watch.

12

Overall view

APS Innovation is a company whose core products are laser notching equipment for secondary batteries. Its revenue fell 49.5% in 2025, yet its operating margin stayed in the 3% range.

Quarterly operating profit rose to KRW 3 billion in Q1 2026 and KRW 4.68 billion in Q3 2026, but dropped to KRW 535 million in Q2 and Q3 brought a KRW 3.41 billion controlling-shareholder net loss.

Controlling-shareholder net income over the latest four quarters totaled KRW 5.77 billion, so earnings capacity is still small. The acquisition of ERAE, the stake in a beauty platform company and the new Cheonan plant are advancing at the same time, reflecting an effort to reduce dependence on battery customers.

Strengths include the Q3 operating profit recovery, early signs of battery demand recovery, a low debt ratio and higher operating cash flow. Weaknesses include dependence on the downstream investment cycle, quarters that swung into loss, and the burden of large investment and acquisition spending.

Both sets of factors deserve equal weight, and the reading of valuation will depend on next quarter's operating margin and on how the new facility performs.

The next checkpoints are the Cheonan plant completion in late January 2027, the merger completion involving ERAE and a related company, and the 2026 annual business report. This material is provided for information only and contains no buy or sell opinion.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 15 more articles and sources
  1. comp.wisereport.co.kr
  2. bloter.net
  3. zdnet.co.kr
  4. m.news.nate.com
  5. m.news.nate.com
  6. sedaily.com
  7. newspim.com
  8. kmnanews.com
  9. newspim.com
  10. kpinfo.kr
  11. jobkorea.co.kr
  12. datatooza.com
  13. markets.hankyung.com
  14. investing.com
  15. newspim.com

Report written 2026-11-14 · Data as of 2026-11-13

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis